跳至主要内容
临床试验/NCT04351737
NCT04351737已完成4 期

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation ComparEd to StandaRd of Care Topical Cortico-Steroid Treatment In PatientS Who Undergo BilaTeral Pterygium Surgery PERSIST Study

Brandon Eye Associates, PA1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Patient pain level follow pterygium removal

研究概览

简要总结

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery

详细描述

In patients who undergo bilateral pterygium surgery, eyes will be randomized to receive either DEXTENZA at baseline, Month 1 and Month 2 or prednisolone x 3 months. Both eyes will receive antibiotic drops four times per day for two weeks and Maxitrol ointment at bedtime for two weeks following surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with bilateral pterygium -

排除标准

  • 未提供

研究组 & 干预措施

Pterygium patients

Experimental

patients with bilateral pterytium

干预措施: Intracanalicular Dexamethasone, (0.4 mg) Insert (Drug)

Pterygium patients

Experimental

patients with bilateral pterytium

干预措施: Prednisolone Acetate (Drug)

结局指标

主要结局

Patient pain level follow pterygium removal

时间窗: 2 months

measurement of pain following pterygium removal using the validated "Numeric Pain Rating Scale" to assess pain, which ranges from 0 to 10 with higher values indicating more severe pain.

inflammation

时间窗: 2 months

measurement of ocular surface inflammation using the standard 1+ - 4+ rating scale commonly used in ophthalmology with 4+ indicating the most inflammation.

次要结局

未报告次要终点

研究者

发起方
Brandon Eye Associates, PA
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Dextenza for Post-operative Treatment of Pterygium | 临床试验